Novo Nordisk is seeking Chinese approval for its oral weight loss pill
China's drug regulator accepted Novo Nordisk's application for an oral version of Wegovy as the Danish company competes with Eli Lilly in the market
Real-time health news from China, structured for developers. NewsMesh filters China-relevant health coverage into one JSON feed (GET /v1/latest?category=health&country=cn), each story tagged with category, country relevance, and the named people detected in the body.
China's drug regulator accepted Novo Nordisk's application for an oral version of Wegovy as the Danish company competes with Eli Lilly in the market
Created for the in-between years, Siiiba is reimagining personal care for pre-teens and teens with products designed to make growing up feel a little less awkward
The 6-step routine focuses on scalp health and shinier, healthier hair.
China's drug regulator has approved Johnson & Johnson's oral pill for psoriasis, the company said on Thursday, intensifying competition in the world's second-largest... Reuter...
Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tr...
A real-world study suggests Zepbound use could reduce the rates of hospital stays and ER visits. Elsewhere, McKesson sprung for a multibillion-dollar deal and J&J nabbed a notew...
Jaw-dropping patient videos and miraculous testimonials ignited a frenzy in China over a technique that aims to improve drainage from the brain in dementia patients. Now it is e...
Scientists in China have created a self-exercising muscle graft that could allow bedridden people to obtain the benefits of working out without any physical exertion. With just ...
A 90-year-old woman in Beijing is devoted to caring for her husband with Alzheimer’s disease, determined to safeguard not only his health but also his dignity. Wen Bo and her hu...
MindRank, a Hangzhou drug developer built around AI, says its lead candidate went from programme initiation to Phase III trials in roughly four and a half years on about $23mn o...
A real-world study suggests Zepbound use could reduce the rates of hospital stays and ER visits. Elsewhere, McKesson sprung for a multibillion-dollar deal and J&J nabbed a notew...
A Chinese woman developed life-threatening muscle breakdown after her company forced her to perform 200 squats as punishment for unfinished work. The young woman, surnamed Yang,...
A group of Hong Kong-listed biotechnology companies have seen their stock prices surge in the wake of Moderna’s breakthrough cancer vaccine trial, as the Chinese companies push ...
Backed by sustained government investment, regulatory reform and growing biotech ecosystems, China, Japan and South Korea are reshaping global drug development and offering valu...
A street food vendor in central China received widespread acclaim after discreetly slipping 100 yuan (US$15) into a takeaway order for a family whose child was undergoing chemot...
A woman from central China undertook a fasting regimen for half a month and lost 20kg, but ultimately suffered from a serious brain disorder from which she may never fully recov...
Local restrictions prevent drug companies from directly advertising prescription medicines in the world's second-largest drug market.
Struggling insomniacs may find relief with a "crapsule" before bedtime, according to new research from China.
How a 'symbolic reset can create a true sense of belonging
NewsMesh filters China-relevant health coverage into one structured feed, ready to query by the same parameters as the rest of the API.
Authenticate with your apiKey and call one endpoint (GET api.newsmesh.co/v1/latest?category=health&country=cn). The examples below are ready to copy.
curl "https://api.newsmesh.co/v1/latest?apiKey=nm_xxx&category=health&country=cn&limit=20"GET /v1/latest: Most-recent articles, filterable by category, country, and date range.GET /v1/search: Full-text search across the archive with boolean operators and source filters.GET /v1/trending: Cached trending headlines, the fastest endpoint for homepage feeds.GET /v1/article/{id}: Fetch a single article and its full metadata by ID.NewsMesh filters China-relevant health coverage into one structured feed, each story tagged with its category, the countries it's relevant to, and the named people detected in the body.
Call GET /v1/latest?category=health&country=cn. Use /v1/search to add keyword queries on top of the same filters.
Yes. Swap the category parameter (business, sports, technology, health, and more) or drop it entirely to get all China coverage from /v1/latest?country=cn.
Yes. NewsMesh is a real-time news API: health China stories are served through the live /v1/latest and /v1/trending endpoints alongside a searchable archive, each tagged with its category, the countries it's relevant to, and the named people detected in the body, so you can build a live feed without scraping HTML.
Create a NewsMesh account, generate an API key, and call the endpoint above with your apiKey parameter. See the pricing page for current plans and rate limits.
Access the full dataset programmatically with the NewsMesh API.